Kenya Updates
Kenya Profile Updated
Jul 2, 2024 - The Kenya profile in ClinRegs has been reviewed and updated with the following information:Minor revisions to the Pharmacy and Poisons Board (PPB) guidance for the conduct of clinical trials, including an updated definition of investigational product, name change for the PPB clinical trial ...
Kenya Profile Updated
Mar 3, 2023 - The Kenya profile in ClinRegs has been reviewed and updated with the following information:
New regulations and updated guidelines issued in 2022 on the conduct of clinical trials in Kenya (See Regulatory Authority, Clinical Trial Lifecycle, Sponsorship, Informed Consent, and Investigational ...
Kenya Profile Updated
Jan 27, 2022 - The Kenya profile in ClinRegs has been reviewed and updated with the following information:
Updates to the National Guidelines for Ethical Conduct of Biomedical Research Involving Human Participants in Kenya (See Submission Content, and the Ethics ...
Kenya Profile Updated in ClinRegs
Mar 9, 2021 - The Kenya profile in ClinRegs has been updated to include the following information:
Guidelines on Research Licensing and Institutional Affiliation: A National Commission for Science, Technology, and Innovation (NACOSTI) guidance for submitting research license applications, ...
Kenya Profile Updated in ClinRegs
Jun 26, 2020 - The Kenya profile in ClinRegs now includes the following updates:
Amendments to the Pharmacy and Poisons Act, enacted through the Health Laws (Amendment) Act, 2019 (See Regulatory Authority and Investigational Products topics)
An updated version ...
Kenya: PPB Issues Guidance for Clinical Trials Impacted by COVID-19
Apr 16, 2020 - Kenya’s Pharmacy and Poisons Board (PPB) has issued Guidance to Sponsors and Investigators for Conduct of Clinical Trials during the COVID-19 Pandemic in Kenya, which takes effect April 20, 2020. The guidance addresses the following topics:
Management of and amendments to existing ...
Select the checkbox to filter the updates